Abstract
Background and hypothesis: The implantable cardioverter defibrillator (ICD) is the best available strategy to protect patients from life‐threatening ventricular arrhythmia. Although unproven, it is commonly utilized to treat subjects with syncope, a negative clinical workup, structural heart disease, and inducible sustained monomorphic ventricular tachycardia (VT) on programmed electrophysiologic stimulation (EPS). The purpose of this paper was to validate this approach.
Methods: We retrospectively identified 36 subjects who received primary ICD therapy for syncope in the setting of structural heart disease with inducible sustained monomorphic VT on EPS. The cohort was predominantly male (32/36) with underlying coronary artery disease (29/36). The mean left ventricular ejection fraction was 31 ± 12%, and a third of the patients (12/36) had undergone bypass surgery.
Results: The study group was followed for a mean of 23 ± 15 months (range 3–81 months) and experienced an ICD event rate of 22% at 3 months, which increased to 55% at 36 months. This event rate was comparable with the 66% event rate seen in a group of patients with primary ICD therapy for spontaneous life‐threatening VT treated during the same time period. No future predictors of ICD events in the study group could be identified.
Conclusion: Syncope patients with negative workup, structural heart disease, and sustained monomorphic VT at EPS are at high risk for future tachyarrhythmic events. Based on present evidence, primary ICD therapy in this group appears warranted and justified.
Keywords: syncope, ventricular tachycardia, implantable cardioverter defibrillator
Full Text
The Full Text of this article is available as a PDF (642.4 KB).
References
- 1. Eagle KA, Black HR, Cook EF, Goldman L: Evaluation of prognostic classifications for patients with syncope. Am J Med 1985; 79: 455–460 [DOI] [PubMed] [Google Scholar]
- 2. Silverstein MD, Singer DE, Mulley AG, Thibault GE, Barnett GO: Patients with syncope admitted to medical care units. J Am Med Assoc 1982; 248: 1185–1189 [PubMed] [Google Scholar]
- 3. Kapoor WN, Karpf M, Wieland S, Peterson JR, Levey GS: A prospective evaluation and follow up of patients with syncope. N Engl J Med 1983: 309; 197–204 [DOI] [PubMed] [Google Scholar]
- 4. Doherty JU, Pembrook‐Rogers D, Grogan EW, Falcone RA, Buxton AE, Marchlinski FE, Cassidy DM, Kienzle MG, Almendral JM, Josephson ME: Electrophysiologic evaluation and follow up characteristics of patients with recurrent unexplained syncope and presyncope. Am J Cardiol 1985; 55: 703–708 [DOI] [PubMed] [Google Scholar]
- 5. Olshansky B, Mazuz M, Martins JB: Significance of inducible tachycardia in patients with syncope of unknown origin: A long term follow up. J Am Coll Cardiol 1985; 5: 216–223 [DOI] [PubMed] [Google Scholar]
- 6. Denes P, Uretz E, Ezri MD, Borbola J: Clinical predictors of electrophysiologic findings in patients with syncope of unknown origin. Arch Intern Med 1988; 148: 1922–1928 [PubMed] [Google Scholar]
- 7. Lacroix D, Dubuc M, Kus T, Savard P, Shenasa M, Nadeau R: Evaluation of arrhythmic causes of syncope: Correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping. Am Heart J 1991; 122: 1346–1354 [DOI] [PubMed] [Google Scholar]
- 8. Denniss AR, Ross DL, Richards DA, Uther JB: Electrophysiologic studies in patients with unexplained syncope. Int J Cardiol 1992; 35: 211–217 [DOI] [PubMed] [Google Scholar]
- 9. Morady F, Higgins J, Peters RW, Schwartz AB, Shen EN, Bhandari A, Scheinman MM, Suave MJ: Electrophysiologic testing in bundle‐branch block and unexplained syncope. Am J Cardiol 1984; 54: 587–591 [DOI] [PubMed] [Google Scholar]
- 10. Moazez F, Peter T, Simonson J, Mandel WJ, Vaughn C, Gang E: Syncope of unknown origin: Clinical, noninvasive, and electrophysiologic determinants of arrhythmia induction and symptom recurrence during long term follow up. Am Heart J 1991; 121: 81–88 [DOI] [PubMed] [Google Scholar]
- 11. Morady F, Shen E, Schwartz A, Hess D, Bhandari A, Sung RJ, Scheinman MM: Long term follow up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol 1983; 2: 1053–1059 [DOI] [PubMed] [Google Scholar]
- 12. The AVID Investigators : A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near‐fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576–1583 [DOI] [PubMed] [Google Scholar]
- 13. Moss AJ, Hall WJ, Cannon DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilbur D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933–1940 [DOI] [PubMed] [Google Scholar]
- 14. Bigger JT Jr: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997; 337: 1569–1575 [DOI] [PubMed] [Google Scholar]
- 15. Fogoros RN: Why the AVID trial sets the wrong precedent. Am J Cardiol 1997; 80: 762–765 [DOI] [PubMed] [Google Scholar]
- 16. Josephson ME, Nisam S: The AVID Trial: Evidence based or randomized controlled trials—is the AVID study too late? Am J Cardiol 1997; 80: 194–197 [DOI] [PubMed] [Google Scholar]
- 17. Lessmeier TJ, Lehmann MH, Steinman RT, Fromm BS, Akhtar M, Calkins H, DiMarco JP, Epstein AE, Estes NA, Fogoros RN: Implantable cardioverter‐defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation. Am Heart J 1994; 128: 211–218 [DOI] [PubMed] [Google Scholar]
- 18. Lessmeier TJ, Lehmann MH, Steinman RT, Fromm BS, Akhtar M, Calkins H, DiMarco JP, Epstein AE, Estes NA, Fogoros RN: Outcome with implantable cardioverter‐defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarction. Am J Cardiol 1993; 72: 911–915 [DOI] [PubMed] [Google Scholar]
- 19. Wever EF, Hauer RN, van Capelle FL, Tijssen JG, Crijns HJ, Algra A, Wiesfeld ACP, Bakker PFA, Robles de Medina, EO : Randomized study of implantable defibrillator as first choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995: 91; 2195–2203 [DOI] [PubMed] [Google Scholar]
- 20. Link MS, Costeas XF, Griffith JL, Colburn CD, Estes NA, Wang PJ: High incidence of appropriate implantable cardioverter‐defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol 1997; 29: 370–375 [DOI] [PubMed] [Google Scholar]
- 21. Militianu A, Salacata A, Seibert K, Kehoe R, Baga JJ, Meissner MD, Pires LA, Schuger CD, Steinman RT, Mesteller RD, Patti HJ, David JB, Lessmeier TJ, Lehmann HH: Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near syncope. J Cardiovasc Electrophysiol 1997; 8: 1087–1097 [DOI] [PubMed] [Google Scholar]
- 22. Larsen GC, Stupey MR, Walance CG, Griffith KK, Cutler JE, Kron J, McAnulty JH: Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions. J Am Med Assoc 1994; 271: 1335–1339 [PubMed] [Google Scholar]
- 23. Bass EB, Elson JJ, Fogoros RN, Peterson J, Arena VC, Kapoor W: Long term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. Am J Cardiol 1988; 62: 1186–1191 [DOI] [PubMed] [Google Scholar]
- 24. Click RL, Gersh BJ, Sugrue DD, Holmes DR, Wood DL, Osborn MJ, Hammil SC: Role of invasive electrophysiologic testing in patients with symptomatic bundle‐branch block. Am J Cardiol 1987; 59: 817–823 [DOI] [PubMed] [Google Scholar]
- 25. Kelly PA, Cannom DS, Garan H, Finkelstein D, McComb JM, Mirabal GS, Ilvento JP, Ruskin JN: Predictors of automatic implantable cardioverter‐defibrillator discharge for life threatening ventricular arrhythmias. Am J Cardiol 1988; 62: 83–87 [DOI] [PubMed] [Google Scholar]
- 26. Tebbenjohanns J, Schumacher B, Jung W, Korte T, Pfeiffer D, Manz M, Luderitz B: Predictors of outcome in patients with implantable transvenous cardioverter defibrillators. Am Heart J 1994; 127: 1086–1089 [DOI] [PubMed] [Google Scholar]
- 27. Connoly SJ, Gent M, Roberts RS, Dorian P, Green MS, Klein GJ, Mitchell LB, Sheldon RS, Raj D: Canadian Implantable Defibrillator Study (CIDS): Study design and organization. Am J Cardiol 1993; 72: 103F–108F [DOI] [PubMed] [Google Scholar]